Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
30,198,594
-
Share change
-
-607,264
-
Total reported value
-
$798,146,249
-
Put/Call ratio
-
1746%
-
Price per share
-
$26.43
-
Number of holders
-
98
-
Value change
-
-$10,957,427
-
Number of buys
-
48
-
Number of sells
-
47
Institutional Holders of G1 THERAPEUTICS INC - COM (GTHX) as of Q4 2019
As of 31 Dec 2019,
G1 THERAPEUTICS INC - COM (GTHX) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,198,594 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, MPM ONCOLOGY IMPACT MANAGEMENT LP, STATE STREET CORP, HILLHOUSE CAPITAL ADVISORS, LTD., and Bellevue Group AG.
This page lists
98
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.